Decreased Expression of Cyclic Adenosine Monophosphate-Regulated Aldose Reductase (AKR1B1) Is Associated with Malignancy in Human Sporadic Adrenocortical Tumors

Anne-Marie Lefrançois-Martinez (1) , Jérôme Bertherat (2) , Pierre Val (1) , Colette Tournaire (3) , Nicole Gallo-Payet (4) , David Hyndman , Georges Veyssière (5) , Xavier Bertagna (6) , Claude Jean (5) , Antoine Martinez (1)

1 GReD - Génétique, Reproduction et Développement
2 IC UM3 (UMR 8104 / U1016) - Institut Cochin
3 BPMP - Biochimie et Physiologie Moléculaire des Plantes
4 UdeS - Université de Sherbrooke
5 UBP - Université Blaise Pascal - Clermont-Ferrand 2
6 UMR_S567 / UMR 8104 - Institut Cochin

Domaines: Sciences du Vivant [q-bio]

Anne-Marie Lefrançois-Martinez, Jérôme Bertherat, Pierre Val, Colette Tournaire, Nicole Gallo-Payet, et al.. Decreased Expression of Cyclic Adenosine Monophosphate-Regulated Aldose Reductase (AKR1B1) Is Associated with Malignancy in Human Sporadic Adrenocortical Tumors. Journal of Clinical Endocrinology and Metabolism, 2004, 89 (6), pp.3010-3019. ⟨10.1210/jc.2003-031830⟩. ⟨hal-02366486⟩